Literature DB >> 2998874

Activation of the PCSM-protein phosphatase by a Ca2+-dependent protease.

E Waelkens, J Goris, W Merlevede.   

Abstract

The inhibitor-1 phosphatase but not the phosphorylase phosphatase activity of a newly discovered 250 kDa polycation-stimulated (PCSM) protein phosphatase in rabbit skeletal muscle is increased up to 10-fold by a Ca2+-dependent protease. The enzyme-directed protease effect to which the PCSH and PCSL phosphatases are insensitive was progressively lost during purification of the enzyme. This could be explained by either a slow conversion of the enzyme to an active form of the enzyme with a change in specificity, or the loss of a protease-sensitive inhibitor of the inhibitor-1 phosphatase activity, resulting in a PCS phosphatase characterized by its high inhibitor-1/phosphorylase alpha activity ratio. The Ca2+-dependent protease is completely inhibited by EGTA or leupeptin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998874     DOI: 10.1016/0014-5793(85)80133-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Specificity of protein phosphatases in the dephosphorylation of protein kinase C.

Authors:  P J Parker; J Goris; W Merlevede
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

2.  Identification of the phosphatase deinhibitor protein phosphatases in rabbit skeletal muscle.

Authors:  J Goris; E Waelkens; W Merlevede
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

3.  The calcium-dependent proteolytic system calpain-calpastatin in Drosophila melanogaster.

Authors:  M Pintér; P Friedrich
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

4.  Poly-L-arginine enhances paracellular permeability via serine/threonine phosphorylation of ZO-1 and tyrosine dephosphorylation of occludin in rabbit nasal epithelium.

Authors:  Kazuo Ohtake; Takuya Maeno; Hideo Ueda; Masahiko Ogihara; Hideshi Natsume; Yasunori Morimoto
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.